Piper Jaffray Initiates Antares Pharma With Overweight

By: via Benzinga
Piper Jaffray initiated coverage on Antares Pharma Inc (NASDAQ: ATRS) with a Overweight rating. The target price for Antares Pharma ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.